Application 208043
- Type
- ANDA
- Sponsor
- ACTAVIS LABS FL INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE;BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE; ORAL | 8MG/90MG | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72951 | ORIG | 2022-12-20 |